Valuation: AstraZeneca PLC

Market Cap 30TCr 26TCr 24TCr 22TCr 43TCr 28,50800Cr 43TCr 2,88800Cr 1,12300Cr 14,01300Cr 1,12400Cr 1,10000Cr 48,28900Cr P/E 2026 *
24.1x
P/E 2027 * 21.2x
Enterprise Value 32TCr 28TCr 26TCr 24TCr 45TCr 30,34100Cr 46TCr 3,07300Cr 1,19500Cr 14,91400Cr 1,19600Cr 1,17000Cr 51,39400Cr EV / Sales 2026 *
5.04x
EV / Sales 2027 * 4.65x
Free-Float
96.63%
Yield 2026 *
1.73%
Yield 2027 * 1.82%
1 day-2.01%
1 week-0.60%
Current month+0.66%
1 month+5.32%
3 months-2.35%
6 months+4.00%
Current year+7.51%
1 week 1,786.5
Extreme 1786.5
1,895.5
1 month 1,658
Extreme 1658
1,895.5
Current year 1,601.5
Extreme 1601.5
1,925.5
1 year 1,316
Extreme 1316
1,925.5
3 years 1,226
Extreme 1226
1,925.5
5 years 960.3
Extreme 960.3
1,925.5
10 years 461.3
Extreme 461.3
1,925.5
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Compliance Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.23%-0.60% - - 30TCr
-1.42%+0.48%+55.50%+160.66% 1,08200Cr
-1.30%+3.29%+68.60%+61.56% 63TCr
-0.85%+3.05%+37.93%+89.70% 46TCr
-2.45%+1.37%+31.00%+23.05% 34TCr
-1.32%+0.57%+30.03%+44.77% 29TCr
-1.67%+2.81%-26.62%-40.17% 22TCr
-1.11%+4.41%+25.45%+65.64% 20TCr
+0.05%+2.65%+17.47%+69.95% 16TCr
-1.27%+0.12%-4.18%-33.30% 14TCr
Average -1.08%+4.65%+26.13%+49.10% 39.24TCr
Weighted average by Cap. -1.11%+5.70%+40.14%+81.06%

Financials

2026 *2027 *
Net sales 6.33TCr 5.53TCr 5.08TCr 4.74TCr 8.98TCr 6,02300Cr 9.12TCr 61TCr 24TCr 2,96100Cr 24TCr 23TCr 10,20200Cr 6.69TCr 5.85TCr 5.38TCr 5.01TCr 9.5TCr 6,37000Cr 9.65TCr 65TCr 25TCr 3,13100Cr 25TCr 25TCr 10,79100Cr
Net income 1.25TCr 1.09TCr 1TCr 933.37Cr 1.77TCr 1,18700Cr 1.8TCr 12TCr 4.67TCr 58TCr 4.68TCr 4.58TCr 2,01000Cr 1.4TCr 1.22TCr 1.12TCr 1.05TCr 1.98TCr 1,33000Cr 2.01TCr 13TCr 5.24TCr 65TCr 5.24TCr 5.13TCr 2,25300Cr
Net Debt 1.92TCr 1.68TCr 1.55TCr 1.44TCr 2.73TCr 1,83300Cr 2.78TCr 19TCr 7.22TCr 90TCr 7.23TCr 7.07TCr 3,10500Cr 1.18TCr 1.03TCr 944.48Cr 880.36Cr 1.67TCr 1,11900Cr 1.7TCr 11TCr 4.41TCr 55TCr 4.41TCr 4.32TCr 1,89600Cr
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
06/26/06 SEK 1,831.50 -1.69% 93,433
03/26/03 SEK 1,863.00 -0.96% 1,63,604
02/26/02 SEK 1,881.00 +4.94% 2,63,069
01/26/01 SEK 1,792.50 -1.48% 1,48,197
30/26/30 SEK 1,819.50 -1.25% 2,65,687
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
193.04USD
Average target price
217.23USD
Spread / Average Target
+12.53%

Quarterly revenue - Rate of surprise